Efficacy and tolerability of cefixime in otitis media. A multicentre study in over 25,000 children
1Lederle Laboratories, Pearl River, New York.
Insights
Cefixime effectively treated acute otitis media in over 25,000 children, with 86% showing improvement. This antibiotic demonstrated good tolerability, making it a reliable option for pediatric ear infections.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pharmacology
Background:
- Acute otitis media (AOM) is a common childhood infection.
- Effective antibiotic treatment is crucial for managing AOM and preventing complications.
Purpose of the Study:
- To evaluate the efficacy and tolerability of cefixime in treating AOM in a large pediatric population.
- To provide real-world data on cefixime's performance in a multicentre setting.
Main Methods:
- A large-scale, multicentre clinical study involving 25,863 children diagnosed with AOM.
- Children received a once-daily dosage of cefixime (8 mg/kg) for a minimum of 10 days.
- Efficacy was assessed by cure or improvement rates, and tolerability by reported adverse effects.
Main Results:
- 86% of children treated with cefixime experienced a cure or improvement of their AOM.
- Adverse effects were reported in 11.5% of patients, with only 9.4% attributed to cefixime.
- The efficacy and tolerability align with findings from controlled clinical trials.
Conclusions:
- Cefixime is a highly effective treatment for acute otitis media in children.
- The antibiotic is well-tolerated, supporting its use in pediatric practice.
- This study confirms cefixime's role as a valuable therapeutic option for AOM.
Abstract:
A large scale multicentre clinical study was undertaken to assess the efficacy and tolerability of cefixime in the treatment of acute otitis media in children. A total of 25,863 evaluable children with acute otitis media received cefixime 8 mg/kg once daily for at least 10 days. At the end of treatment, 86% of patients were considered to be either cured or improved. These results are consistent with those achieved with cefixime in controlled clinical trials. Adverse effects were reported in 11.5% of patients, but were judged to be related to cefixime therapy in only 9.4% of patients. The results of this study demonstrate that cefixime is an effective and well tolerated treatment for acute otitis media in children.
Related Concept Videos
Tonsillitis II: Management
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Drug Dosing: Infants and Children
Urine Studies II: Urine Culture and Sensitivity Test
Antimicrobial Effectiveness
Mechanism of Antibiotic Resistance in MRSA


